Search for Clinical Trial Results

Sponsored By

Cytomegalic Inclusion Disease - 25 Studies Found

Status Study
Recruiting Study Name: Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients
Condition: Cytomegalovirus Disease
Date: 2009-01-23
Interventions:
  • Drug: Certican (everolimus) + valganciclovir

Completed Study Name: Cytogam Administration in Abdominal Organ Transplant Recipients at High Risk for Cytomegalovirus Infection
Condition: Cytomegalovirus Disease
Date: 2012-01-10
Interventions:
  • Drug: Valganciclovir Valcyte p
Completed Study Name: A Study of MCMV5322A/MCMV3068A for the Prevention of Cytomegalovirus Disease in High-Risk Kidney Allograft Recipients
Condition: Cytomegalovirus Infections
Date: 2012-12-17
Interventions:
  • Drug: MCMV3068A Four doses of

Terminated Study Name: SUSTAIN: A Randomized, Double-Blind, Multicenter, Phase 3 Study of the Efficacy, Safety, and Tolerability of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus Disease in CMV Seronegative Kidney Allograft Recipients
Condition: Cytomegalovirus Disease
Date: 2015-05-07
Interventions:
  • Drug: Brincidofovir Other Name
Enrolling by invitation Study Name: Screening for Congenital Cytomegalovirus Infection in Newborns
Condition: Cytomegalovirus Infections
Date: 2016-02-11
Interventions: Other: Observation Viable Infants with a failed hearing screen or a diagnosis of SGA who are born at eit
Recruiting Study Name: Preemptive Adoptive CMV-CTL Infusion to Prevent Refractory CMV Infection Post Haplo-HSCT
Condition: CMV Infection
Date: 2016-11-28
Interventions: Biological: Donor-derived CMVpp65-specific T cells About 1 million per kg CMVpp65-specific T cells will
Completed Study Name: Quantiferon - Cytomegalovirus (CMV) and the Prediction of CMV Infection In High Risk Solid Organ Transplant Recipients
Condition: Cytomegalovirus Infection
Date: 2008-10-15
Recruiting Study Name: Evaluation of the PK and PD of Ganciclovir in Premature Infants Receiving Treatment for CMV Infection
Condition: Cytomegalovirus Infections
Date: 2012-05-17
Completed Study Name: Short-Term vs. Long-Term Valganciclovir Therapy for Symptomatic Congenital CMV Infections
Condition: Cytomegalovirus Infection
Date: 2007-04-26
Interventions:
  • Other: Placebo 9 grams of powd
Completed Study Name: Efficacy Study of Human Cytomegalovirus (HCMV) Hyperimmune Globulin to Prevent Congenital HCMV Infection
Condition: Cytomegalovirus Infection
Date: 2009-04-14
Interventions:
  • Drug: HCMV-specific hyperimmune globulin (Cytotect®)

Next >>>